Acinetobacter baumannii as a causative agent of health care associated infections

Miguel Ángel Aguirre Navarrete; Rocío Pérez y Terrón

doi:10.30574/gscbps.2020.13.2.0360

Authors

Miguel Ángel Aguirre Navarrete Autonomous University of Guerrero, Av. Lázaro Cárdenas S/N, City University 39070, Chilpancingo de los Bravo Guerrero, México.
Rocío Pérez y Terrón Microbiology and Molecular Biology Laboratory, Biological Sciences Faculty, Autonomous University of Puebla, Building 112-A, City University C. P. 72570 Puebla, Mexico.

DOI:

https://doi.org/10.30574/gscbps.2020.13.2.0360

Keywords:

Acinetobacter baumannii, Health Care Associated Infections

Abstract

Acinetobacter baumannii is an opportunistic pathogen that seriously affects sick patients, causing Health Care Associated Infections (HCAI) such as pneumonia associated with mechanical ventilation, urinary tract infections and bacteremia, in recent years this bacterium has become a health problem worldwide, its isolation from infections present in hospitalized patients has been increasing, and it also has various mechanisms of resistance to antibiotics. The present documentary research aims to describe the mechanisms of pathogenicity and resistance to antibiotics used by Acinetobacter baumannii as a causal agent of HCAI. To carry out this work, a literature search was carried out in databases such as: Scielo, PubMed, NCBI, and Elsevier. The pathogenicity mechanisms that allow it to colonize and develop infections in hospitalized patients are: porins, biofilms, pili, lipopolysaccharides, phospholipases, outer membrane vesicles and the production of siderophores. It has enzymatic resistance mechanisms such as beta-lactamases and non-enzymatic mechanisms such as porin modification, efflux pumps, and modifications in DNA gyrase. There are extrinsic factors that favor the development of HCAI, such as the immunological and health condition of the patient, as well as the association with medical equipment. Studies carried out between the years 2005 to 2018 reveal that A. baumannii is one of the main causative agents of pneumonia associated with mechanical ventilation in patients admitted to the Intensive care unit.

Metrics

Metrics Loading ...

References

Vanegas JM, Higuita LF, Vargas CA, Cienfuegos AV, Rodríguez ÉA, Roncancio GE et al. Acinetobacter baumannii resistant to carbapenems causing osteomyelitis and skin and soft tissue infections in hospitals in Medellín, Colombia. Biomedica. 2015; 35 (4): 522-30.

Reyes AC. Acinetobacter baumanni: threat to human health. Revi AMC. 2018; 22 (6): 695-698.

Koneman EW, Winn WC, Allen SD, Janda WM, Procop GW, Schreckenberger PC, et al. Koneman´s Color Atlas and Textbook of Diagnostic Microbiology, 6th ed. Madrid, España: Editorial Médica Panamericana. 2006.

Alós J. Bacterial resistance to antibiotics: a global crisis. Enferm Infecc Microbiol Clin. 2015; 33(10): 692-699.

Medina DA, Machado ME and Machado-Alba JE. Antibiotic resistance, a global crisis. Rev Med Risaralda. 2015; 21 (1): 74.

WHO - World Health Organization. Patient Safety: a World Alliance for Safer Health Care. Report on the Burden of Endemic Health Care - Associated Infection Worldwide. A systematic review of the literature. Geneva: WHO; 2011 [cited 2020 Jul. 8]; Available from: https://apps.who.int/iris/bitstream/handle/10665/80135/9789241501507_eng.pdf;jsessionid=033E9D3E23685E915000FFB6D4F9045D?sequence=1

Hart M, Espinosa F, Halley M, Martínez ML and Montes de Oca Z. Antibiotic resistance in Acinetobacter baumannii strains isolated from January to March 2010 in the Clinical Surgical Hospital Hermanos Ameijeiras. Rev Cubana Med. 2010; 49(3): 218-227.

Rodríguez RD, Bustillo DE, Caicedo DC, Cadena DC and Castellanos C. Acinetobacter baumannii: emerging multi-resistant pathogen. Medicas UIS. 2016; 29(2): 113-135.

Vanegas JM, Roncancio and G, Jiménez JN. Acinetobacter baumannii: clinical importance, resistance mechanisms and diagnosis. Rev CES Med. 2014; 28(2): 233-246.

Rada J. Acinetobacter a current pathogen. Rev Bol Ped. 2016; 55(1): 29-48.

Tovar GI, Castillo I, Quiñónez EI, Rodas OR and Vázquez C. Listeria a practical approach to the microorganism. RDU. 2005; 6 (4).

Harding CM, Hennon SW and Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018; 16(2): 91–102.

Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, et al. Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol. 2017; 7(55).

Weber BS, Harding CM and Feldman MF. Pathogenic Acinetobacter: from the cell surface to infinity and beyond. J Bacteriol. 2015; 198(6): 880–887.

Barletta R, Pérez L, Castro G, Pujol M, Barletta del Castillo J and Dueñas Y. Multi-resistant Acinetobacter baumannii: a challenge for current therapy. MediSur. 2018; 16(2): 322-334.

Howard A, O'Donoghue M, Feeney A and Sleator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence. 2012; 3(3): 243-250.

Morejón M. Extended spectrum betalactamases. Rev Cubana Med. 2013; 52(4): 272-280.

Ibrahim ME. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann Clin Microbiol Antimicrob. 2019; 18(1): 1.

López S and López-Brea M. What should we know about Acinetobacter baumannii infections? Enferm Infecc Microbiol Clin. 2000; 18(3): 153-156.

Ayoub C and Hammoudi D. Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen. Antibiotics. 2020; 9(3): 119.

Opazo A, Mella S, Domínguez M, Bello H and González G. Multi-drug efflux pumps and antibiotic resistance in Acinetobacter baumannii. Rev Chilena Infectol. 2009; 26(6): 499-503.

Vecchiola M. Acinetobacter Infections. Rev Chilena Infectol. 2008; 25(5): 397-399.

Baquero PJ, Cabarcas WF, Carrillo PX, Gaviria JE, Giraldo B and Barrios FA. Community-acquired Acinetobacter baumannii urinary infection: clinical case of a pregnant patient. Ginecol Obstet Mex. 2018; 86(10): 682-686.

Diomedi A. Pan-resistant Acinetobacter baumannii Infections: Epidemiological Considerations and Updated Antimicrobial Management. Rev Chilena Infectol. 2005; 22(4): 298-320.

Secretary of Health. Informes Red Hospitalaria de Vigilancia Epidemiológica (RHOVE) 2015. Mexico: Government of Mexico; 2017 [cited 2020 Jul 30]. Available at https://www.gob.mx/salud/documentos/informes-rhove-2015

Oliveira A, Marques AK and Prado MA. Infections related to health care in neonatal intensive care units: an integrative review. Enferm Glob. 2017; 16(45): 508-536.

Gómez GE, Buena SM and Vega ME. Resistance profile of microorganisms isolated in the Microbiology Service of the National Hospital in 2017. Rev Nac (Itauguá). 2018; 10(2): 21-38.

Ortega LM, Duque M, Valdés J and Verdasquera D. Severe sepsis in the intensive care unit of the Pedro Kourí Institute of Tropical Medicine. Rev Cubana Salud Pública. 2018; 44(2): 213-223.